Pay in 4 interest-free payments of $6.38 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Eligibility required a body mass index (BMI) of 30 kg/m or higher, or for those with at least one obesity-related comorbidity and no diabetes, a BMI of 27 kg/m or higher
Its already approved for treating HIV in some people
Cagrilintide is engineered for once-weekly dosing in research protocols, making it practical for longitudinal study designs
Effect of food consumption on the pharmacokinetics, safety, and tolerability of once-daily orally administered orforglipron (LY3502970), a non-peptide GLP-1 receptor agonist
US$ 29.74
US$ 23.36
US$ 29.04
US$ 22.68
US$ 21.52
